Accounting Estimates Based on Assumptions Regarding the Impact of COVID-19
First written in FY2021-Q1. 3 of 11 entries say "Mitigated", first in FY2022. Latest entry: FY2023.
The whole theme swung hardest in 2026: 3 of 7 companies on the "Worse" side.
0 other companies' latest entry also says "Mitigated".
- FY2023MitigatedAnnual report
「The company believes that the direct effects of COVID-19 have almost ended, but assumes that a certain degree of impact will persist because changes in consumer preferences will prevent revenue from returning to pre-pandemic levels.」
For its accounting estimates, the company has updated its assumption to reflect that the direct effects of COVID-19 have almost ended, while assuming that the effects of changes in consumer preferences will remain. - FY2023-Q1MitigatedAnnual report
「Based on the situation described above, the company assumes that the effects of COVID-19 are gradually diminishing. Although it will still take time to return to pre-pandemic conditions, the company assumes that recovery will continue as third-dose vaccinations progress and oral treatments are developed and introduced.」
The company stated the accounting estimate assumption that the effects of COVID-19 are gradually diminishing, although recovery to pre-pandemic conditions will still take time. - FY2022MitigatedAnnual report
「We believe that the direct impact of COVID-19 itself has almost subsided. However, because consumer preferences have changed, we assume that sales will not return to pre-COVID-19 levels and that a certain degree of impact will continue.」
The company has updated the assumption underlying its accounting estimates to reflect that the direct effects of COVID-19 have almost ended, but revenue will not return to pre-pandemic levels. - FY2022Update to the assumptions underlying accounting estimatesAnnual report
「Based on the situation described above, the company expects the effects of COVID-19 to continue until around the middle of the first quarter of the fiscal year ending August 2022. However, it expects the effects on consumer behavior to gradually disappear as third-dose vaccinations progress, oral treatments are developed and introduced, and the priority preventive measures are lifted. It therefore assumes that revenue will recover from around the middle of the first quarter of the fiscal year ending August 2022.」
The company has updated its accounting estimate assumption to reflect the effects of COVID-19 continuing until around the middle of the first quarter of the fiscal year ending August 2022, followed by a recovery in revenue. - FY2022-Q3RestatedAnnual report
「Based on the situation described above, the company expects the effects of COVID-19 to continue throughout the current consolidated fiscal year. However, it expects those effects to gradually disappear as third-dose vaccinations progress and oral treatments are developed and introduced, although it will still take time to return to pre-pandemic conditions. It therefore assumes that revenue will recover from fiscal 2022 onward.」
The company continues to use the accounting assumption that the effects of COVID-19 will continue throughout the current consolidated fiscal year, while revenue will recover from fiscal 2022 onward as vaccinations and therapeutic drugs are developed. - FY2022-Q2SoftenedAnnual report
「Based on the situation described above, the company expects the effects of COVID-19 to continue through the end of the current fiscal year. However, as it expects those effects to gradually disappear with progress in vaccinations and the successive announcement of special approvals for therapeutic drugs, it assumes that revenue will recover from fiscal 2022 onward.」
The company stated that the effects of COVID-19 were expected to continue through the end of the current fiscal year and updated its accounting assumption for revenue recovery to fiscal 2022 onward. - FY2022-Q1Update to the assumptions underlying accounting estimatesAnnual report
「In the first half of fiscal 2021, while taking into account actual revenue for the current quarter, the company expects the effects of COVID-19 to gradually disappear as vaccination progresses and assumes that revenue will recover from the end of fiscal 2021 onward.」
The company has updated its assumption to revenue recovery from the end of fiscal 2021 onward, reflecting the slowdown in recovery caused by the priority preventive measures. - FY2021Update to the annual estimate assumptionsAnnual report
「In this situation, partly because COVID-19 vaccines are becoming more widespread, the company assumes that the effects of COVID-19 on revenue will gradually disappear during fiscal 2021.」
The company has updated its assumption to reflect a temporary slowdown in recovery resulting from the reissuance of the state of emergency, while assuming that the effects of COVID-19 will gradually disappear during fiscal 2021 as vaccines become more widespread. - FY2021-Q3Addition of the effects of the state of emergencyAnnual report
「Due to the spread of COVID-19, the company had suspended operations on some floors of its stores from 8 April 2020, but resumed operations throughout the stores on 27 May. Although the effects of COVID-19 remain after the resumption of operations, some recovery has been seen. In this situation, the state of emergency declared on 7 January 2021 is expected to cause a temporary decline in revenue, but revenue is expected to recover gradually, and the company assumes that the effects of COVID-19 will have disappeared from revenue in fiscal 2021. In considering impairment losses on fixed assets and future liquidity related to the going-concern assumption, the company estimated future cash flows by taking into account, in addition to the above assumptions, the effects on revenue of closing the Yokosuka store and commencing operations at a new store.」
While maintaining its previous recovery assumption, the company has added to its future cash-flow estimates the temporary decline in revenue caused by the state of emergency declared in January 2021, as well as the effects of closing the Yokosuka store and commencing operations at a new store. - FY2021-Q2SoftenedAnnual report
「In this situation, the company expects revenue to recover gradually and assumes that the effects of COVID-19 will have disappeared from revenue in fiscal 2021.」
The company has updated its previous assumption that revenue would recover from the middle of fiscal 2020 onward to assume that the effects of COVID-19 will have disappeared by revenue in fiscal 2021. - FY2021-Q1First statedAnnual report
「The company assumes that the effects of COVID-19 will persist for a certain period even after operations resume. Accordingly, for the first half of fiscal 2020, while taking into account actual revenue for the current quarter, it assumes that revenue will not recover until after the middle of fiscal 2020.」
The company has used the assumption that the effects of COVID-19 will persist for a certain period and that revenue will recover from the middle of fiscal 2020 onward in estimating impairment losses and future cash flows related to the going-concern assumption.